|
Real-time Estimate
Cboe BZX
01:36:57 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 159.54 USD | +2.40% |
|
+2.17% | -12.55% |
| Oct. 14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| Oct. 08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.40% | +2.17% | -22.28% | -27.94% | -12.55% | +21.36% | +148.58% | +281.09% | +2,084.88% | 8.16B | |
| +4.51% | +10.88% | +11.04% | +12.78% | +20.36% | +59.89% | +121.24% | +430.72% | +1,542.72% | 1,106B | |
| +2.09% | +4.27% | -3.80% | +4.18% | +25.26% | +33.81% | +69.42% | +58.27% | +125.66% | 612B | |
| +2.57% | +5.47% | +9.41% | +14.21% | +26.65% | +24.70% | +97.89% | +166.93% | +368.56% | 500B | |
| +2.58% | +8.37% | +6.88% | +17.55% | +18.80% | +38.71% | +63.14% | +10.70% | +67.70% | 367B | |
| +2.98% | +4.19% | -1.05% | +18.91% | +40.53% | +71.37% | +44.08% | +82.47% | +138.90% | 354B | |
| +1.85% | +6.04% | +8.92% | +2.76% | +15.42% | +21.47% | +49.17% | +62.76% | +68.22% | 286B | |
| +1.76% | +6.07% | +0.46% | +1.92% | -8.50% | +0.43% | +20.98% | +43.91% | +153.50% | 256B | |
| +2.46% | +5.31% | +10.58% | +19.39% | +32.83% | +43.33% | +55.94% | +107.37% | +169.21% | 230B | |
| +1.62% | +4.87% | +3.04% | +16.46% | +26.39% | +26.01% | +99.40% | +132.02% | +108.76% | 190B | |
| +1.83% | +1.77% | +0.46% | -20.37% | -19.69% | -27.40% | -61.46% | -21.64% | +87.78% | 170B | |
| +2.29% | +6.13% | +8.54% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 168B | |
| +1.34% | +4.62% | -0.60% | +5.65% | +11.98% | +21.13% | +40.29% | +173.68% | +512.22% | 127B | |
| +4.58% | +8.63% | -1.69% | +2.33% | +14.13% | +41.23% | +9.04% | +6.01% | +22.24% | 120B | |
| +1.06% | +6.08% | +15.10% | +22.71% | +24.39% | +29.51% | +125.33% | +395.09% | +530.02% | 118B | |
| +0.73% | +6.59% | -2.22% | -0.72% | +2.41% | +14.39% | +27.80% | +6.15% | -10.25% | 99B | |
| +3.62% | +4.01% | -1.35% | -4.33% | -11.05% | -15.02% | -25.55% | -12.85% | +6.02% | 95.44B | |
| +5.81% | +11.44% | +39.35% | +305.11% | +717.23% | +784.73% | +199.75% | -27.63% | - | 90.58B | |
| +1.97% | +5.52% | -0.44% | +18.23% | +2.95% | +37.78% | -1.71% | +41.22% | +114.06% | 78.09B | |
| +1.42% | +6.40% | +10.41% | +8.48% | +19.41% | +29.61% | -1.61% | -26.08% | +47.51% | 70.41B | |
| Average | +2.45% | +2.02% | +4.54% | +21.95% | +48.39% | +63.95% | +54.00% | +94.03% | +322.64% | 252.26B | |
| Weighted average by Cap. | +2.77% | +2.34% | +5.78% | +15.57% | +31.56% | +48.82% | +68.38% | +152.34% | +470.64% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
